• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆固醇代谢及其在 MASLD 发展中的促炎作用概述。

An overview of the cholesterol metabolism and its proinflammatory role in the development of MASLD.

机构信息

Institute of Life Sciences, School of Basic Medicine, Chongqing Medical University, Chongqing, China.

Center for Life Sciences, Yunnan Key Laboratory of Cell Metabolism and Diseases, School of Life Sciences, Yunnan University, Kunming, Yunnan, China.

出版信息

Hepatol Commun. 2024 May 2;8(5). doi: 10.1097/HC9.0000000000000434. eCollection 2024 May 1.

DOI:10.1097/HC9.0000000000000434
PMID:38696365
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11068152/
Abstract

Cholesterol is an essential lipid molecule in mammalian cells. It is not only involved in the formation of cell membranes but also serves as a raw material for the synthesis of bile acids, vitamin D, and steroid hormones. Additionally, it acts as a covalent modifier of proteins and plays a crucial role in numerous life processes. Generally, the metabolic processes of cholesterol absorption, synthesis, conversion, and efflux are strictly regulated. Excessive accumulation of cholesterol in the body is a risk factor for metabolic diseases such as cardiovascular disease, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease (MASLD). In this review, we first provide an overview of the discovery of cholesterol and the fundamental process of cholesterol metabolism. We then summarize the relationship between dietary cholesterol intake and the risk of developing MASLD, and also the animal models of MASLD specifically established with a cholesterol-containing diet. In the end, the role of cholesterol-induced inflammation in the initiation and development of MASLD is discussed.

摘要

胆固醇是哺乳动物细胞中一种重要的脂质分子。它不仅参与细胞膜的形成,还是胆汁酸、维生素 D 和甾体激素合成的原料。此外,胆固醇还作为蛋白质的共价修饰物,在许多生命过程中发挥着关键作用。通常,胆固醇的吸收、合成、转化和外排代谢过程受到严格的调控。体内胆固醇的过度积累是心血管疾病、2 型糖尿病和代谢功能障碍相关脂肪性肝病(MASLD)等代谢性疾病的一个风险因素。在这篇综述中,我们首先概述了胆固醇的发现和胆固醇代谢的基本过程。然后,我们总结了膳食胆固醇摄入与 MASLD 发病风险的关系,以及专门用含胆固醇饮食建立的 MASLD 动物模型。最后,我们讨论了胆固醇诱导的炎症在 MASLD 的发生和发展中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cca/11068152/f351f991178b/hc9-8-e0434-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cca/11068152/10470c755e71/hc9-8-e0434-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cca/11068152/5ea4d6aeea0b/hc9-8-e0434-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cca/11068152/639a1ec0efa6/hc9-8-e0434-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cca/11068152/be98c363531f/hc9-8-e0434-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cca/11068152/b245649e03ca/hc9-8-e0434-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cca/11068152/51c93cf91d77/hc9-8-e0434-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cca/11068152/f351f991178b/hc9-8-e0434-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cca/11068152/10470c755e71/hc9-8-e0434-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cca/11068152/5ea4d6aeea0b/hc9-8-e0434-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cca/11068152/639a1ec0efa6/hc9-8-e0434-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cca/11068152/be98c363531f/hc9-8-e0434-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cca/11068152/b245649e03ca/hc9-8-e0434-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cca/11068152/51c93cf91d77/hc9-8-e0434-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cca/11068152/f351f991178b/hc9-8-e0434-g007.jpg

相似文献

1
An overview of the cholesterol metabolism and its proinflammatory role in the development of MASLD.胆固醇代谢及其在 MASLD 发展中的促炎作用概述。
Hepatol Commun. 2024 May 2;8(5). doi: 10.1097/HC9.0000000000000434. eCollection 2024 May 1.
2
Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights.维生素 D 与代谢相关脂肪性肝病(MASLD):新的机制见解。
Int J Mol Sci. 2024 Apr 30;25(9):4901. doi: 10.3390/ijms25094901.
3
Probiotic Mixture Ameliorates a Diet-Induced MASLD/MASH Murine Model through the Regulation of Hepatic Lipid Metabolism and the Gut Microbiome.益生菌混合物通过调节肝脂代谢和肠道微生物群改善饮食诱导的 MASLD/MASH 小鼠模型。
J Agric Food Chem. 2024 Apr 17;72(15):8536-8549. doi: 10.1021/acs.jafc.3c08910. Epub 2024 Apr 4.
4
Mechanism of Metabolic Dysfunction-associated Steatotic Liver Disease: Important role of lipid metabolism.代谢功能障碍相关脂肪性肝病的发病机制:脂质代谢的重要作用。
J Clin Transl Hepatol. 2024 Sep 28;12(9):815-826. doi: 10.14218/JCTH.2024.00019. Epub 2024 Sep 3.
5
Dietary phosphate restriction induces hepatic lipid accumulation through dysregulation of cholesterol metabolism in mice.饮食磷酸盐限制通过调节胆固醇代谢诱导小鼠肝脏脂质积累。
Nutr Res. 2013 Jul;33(7):586-93. doi: 10.1016/j.nutres.2013.05.004. Epub 2013 Jun 10.
6
Exploring the Role of Bempedoic Acid in Metabolic Dysfunction Associated Steatotic Liver Disease: Actual Evidence and Future Perspectives.探讨贝匹地酸在代谢功能障碍相关脂肪性肝病中的作用:实际证据与未来展望。
Int J Mol Sci. 2024 Jun 25;25(13):6938. doi: 10.3390/ijms25136938.
7
Lupeol improves bile acid metabolism and metabolic dysfunction-associated steatotic liver disease in mice via FXR signaling pathway and gut-liver axis.羽扇豆醇通过 FXR 信号通路和肠-肝轴改善胆汁酸代谢和代谢相关脂肪性肝病。
Biomed Pharmacother. 2024 Aug;177:116942. doi: 10.1016/j.biopha.2024.116942. Epub 2024 Jun 17.
8
Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.代谢相关脂肪性肝病中自噬、铁死亡、细胞凋亡和细胞焦亡
Front Biosci (Landmark Ed). 2024 Jan 19;29(1):30. doi: 10.31083/j.fbl2901030.
9
Liver tissue lipids in metabolic dysfunction-associated steatotic liver disease with diabetes and obesity.代谢功能障碍相关脂肪性肝病合并糖尿病和肥胖患者的肝脏组织脂质
Clin Res Hepatol Gastroenterol. 2024 Aug;48(7):102402. doi: 10.1016/j.clinre.2024.102402. Epub 2024 Jun 21.
10
MicroRNA-411-5p alleviates lipid deposition in metabolic dysfunction-associated steatotic liver disease by targeting the EIF4G2/FOXO3 axis.MicroRNA-411-5p 通过靶向 EIF4G2/FOXO3 轴缓解代谢相关脂肪性肝病中的脂质沉积。
Cell Mol Life Sci. 2024 Sep 11;81(1):398. doi: 10.1007/s00018-024-05434-6.

引用本文的文献

1
Review of methods for the determination of cellular cholesterol content: principles, advantages, limitations, applications, and perspectives.细胞胆固醇含量测定方法综述:原理、优点、局限性、应用及展望。
Anal Sci. 2025 Aug 27. doi: 10.1007/s44211-025-00842-5.
2
Allolobophora caliginosa as bioindicator for chitosan-saponin-bentonite nanocomposite contaminated soil.作为壳聚糖-皂苷-膨润土纳米复合材料污染土壤生物指示物的暗异唇蚓
Sci Rep. 2025 Jul 2;15(1):23670. doi: 10.1038/s41598-025-07708-w.
3
Chitosan-Based Nanoparticles Targeted Delivery System: In Treatment Approach for Dyslipidemia.
基于壳聚糖的纳米颗粒靶向递送系统:在血脂异常治疗方法中的应用
Int J Nanomedicine. 2025 May 24;20:6611-6636. doi: 10.2147/IJN.S517492. eCollection 2025.
4
Epithelial barrier hypothesis in the context of nutrition, microbial dysbiosis, and immune dysregulation in metabolic dysfunction-associated steatotic liver.代谢功能障碍相关脂肪性肝病中营养、微生物群失调和免疫失调背景下的上皮屏障假说
Front Immunol. 2025 May 14;16:1575770. doi: 10.3389/fimmu.2025.1575770. eCollection 2025.
5
27-Hydroxycholesterol in cancer development and drug resistance.27-羟基胆固醇在癌症发生发展及耐药性中的作用
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2507670. doi: 10.1080/14756366.2025.2507670. Epub 2025 May 22.
6
Nonlinear associations of the hs-CRP/HDL-C index with metabolic dysfunction-associated steatotic liver disease and advanced liver fibrosis in US adults: insights from NHANES 2017-2018.美国成年人中hs-CRP/HDL-C指数与代谢功能障碍相关脂肪性肝病及晚期肝纤维化的非线性关联:来自2017 - 2018年美国国家健康与营养检查调查(NHANES)的见解
Sci Rep. 2025 Feb 3;15(1):4029. doi: 10.1038/s41598-025-88685-y.
7
Bridging the gap: The GOLM1-OPN-ABCG5 axis in MASH and gallstone disease: Editorial on "GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers".弥合差距:MASH和胆结石疾病中的GOLM1-OPN-ABCG5轴:关于“GOLM1通过ABCG5介导的MASH肝脏中胆固醇流出促进胆固醇胆结石形成”的社论
Clin Mol Hepatol. 2025 Apr;31(2):631-634. doi: 10.3350/cmh.2025.0066. Epub 2025 Feb 3.
8
Estimating the prevalence of adults at risk for advanced hepatic fibrosis using FIB-4 in a Swiss tertiary care hospital.在瑞士一家三级护理医院中,使用FIB-4评估有进展性肝纤维化风险的成年人患病率。
PLoS One. 2025 Jan 24;20(1):e0317629. doi: 10.1371/journal.pone.0317629. eCollection 2025.
9
Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis.代谢功能障碍相关脂肪性肝病和代谢功能障碍相关脂肪性肝炎中心血管风险的降低
Curr Cardiol Rep. 2025 Jan 18;27(1):28. doi: 10.1007/s11886-024-02185-5.
10
Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).饮食对肠道微生物群的影响及其在代谢功能障碍相关脂肪性肝病(MASLD)中的作用
Nutrients. 2024 Dec 31;17(1):143. doi: 10.3390/nu17010143.